fda decision tirzepatide approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Eli Lilly Gets FDA Approval
Description
Those looking for steady, manageable results
Wondering why your eye is twitching

New clinical publication from Prime Therapeutics explores the latest insights for GLP-1s, including trends in spend, drugs in the pipeline, management strategies and more
Exploring the emerging research on GLP-1 receptor agonists and Parkinson's disease: understand the science, clinical trials, potential benefits, risks, and why these diabetes medications are being investigated for neuroprotection.

Bad breath may signal a complication of diabetes
Direct-pay membership, telehealth statewide.
